Venkataraman Balasubramanian
Examiner (ID: 17374, Phone: (571)272-0662 , Office: P/1624 )
Most Active Art Unit | 1624 |
Art Unit(s) | 1624, 1611 |
Total Applications | 2999 |
Issued Applications | 2017 |
Pending Applications | 254 |
Abandoned Applications | 728 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 377105
[patent_doc_number] => 07312205
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-12-25
[patent_title] => 'Methods and compositions for inhibiting tumor growth'
[patent_app_type] => utility
[patent_app_number] => 10/545143
[patent_app_country] => US
[patent_app_date] => 2004-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3324
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/312/07312205.pdf
[firstpage_image] =>[orig_patent_app_number] => 10545143
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/545143 | Methods and compositions for inhibiting tumor growth | Feb 10, 2004 | Issued |
Array
(
[id] => 7034250
[patent_doc_number] => 20050032760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Continuous process for the production of r-rofleponide'
[patent_app_type] => utility
[patent_app_number] => 10/495692
[patent_app_country] => US
[patent_app_date] => 2004-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2609
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032760.pdf
[firstpage_image] =>[orig_patent_app_number] => 10495692
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/495692 | Continuous process for the production of r-rofleponide | Feb 8, 2004 | Abandoned |
Array
(
[id] => 7152128
[patent_doc_number] => 20040171853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Microbial process to prepare5-androsten-3beta,7alpha, 15alpha-triol-17-one and related analogues'
[patent_app_type] => new
[patent_app_number] => 10/772527
[patent_app_country] => US
[patent_app_date] => 2004-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2679
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20040171853.pdf
[firstpage_image] =>[orig_patent_app_number] => 10772527
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/772527 | Microbial process to prepare5-androsten-3beta,7alpha, 15alpha-triol-17-one and related analogues | Feb 4, 2004 | Abandoned |
Array
(
[id] => 7378049
[patent_doc_number] => 20040220154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Topical testosterone formulations and associated methods'
[patent_app_type] => new
[patent_app_number] => 10/765003
[patent_app_country] => US
[patent_app_date] => 2004-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17410
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20040220154.pdf
[firstpage_image] =>[orig_patent_app_number] => 10765003
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/765003 | Topical testosterone formulations and associated methods | Jan 25, 2004 | Abandoned |
Array
(
[id] => 7378090
[patent_doc_number] => 20040220160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Topical testosterone formulations and associated methods'
[patent_app_type] => new
[patent_app_number] => 10/765004
[patent_app_country] => US
[patent_app_date] => 2004-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17410
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20040220160.pdf
[firstpage_image] =>[orig_patent_app_number] => 10765004
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/765004 | Topical testosterone formulations and associated methods | Jan 25, 2004 | Abandoned |
Array
(
[id] => 5835620
[patent_doc_number] => 20060247452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Method for obtaining 17sg(a)-acetoxy-11$g(b)-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione'
[patent_app_type] => utility
[patent_app_number] => 10/542821
[patent_app_country] => US
[patent_app_date] => 2004-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4217
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20060247452.pdf
[firstpage_image] =>[orig_patent_app_number] => 10542821
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/542821 | Method for obtaining 17sg(a)-acetoxy-11$g(b)-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione | Jan 20, 2004 | Abandoned |
Array
(
[id] => 7677152
[patent_doc_number] => 20040152674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Pharmaceutically active compounds and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 10/762081
[patent_app_country] => US
[patent_app_date] => 2004-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12955
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152674.pdf
[firstpage_image] =>[orig_patent_app_number] => 10762081
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/762081 | Pharmaceutically active compounds and methods of use thereof | Jan 19, 2004 | Abandoned |
Array
(
[id] => 92260
[patent_doc_number] => 07732432
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-08
[patent_title] => '17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators'
[patent_app_type] => utility
[patent_app_number] => 10/540757
[patent_app_country] => US
[patent_app_date] => 2004-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9572
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/732/07732432.pdf
[firstpage_image] =>[orig_patent_app_number] => 10540757
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/540757 | 17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators | Jan 15, 2004 | Issued |
Array
(
[id] => 7255715
[patent_doc_number] => 20050075379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis'
[patent_app_type] => utility
[patent_app_number] => 10/759617
[patent_app_country] => US
[patent_app_date] => 2004-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 13456
[patent_no_of_claims] => 260
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20050075379.pdf
[firstpage_image] =>[orig_patent_app_number] => 10759617
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/759617 | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis | Jan 15, 2004 | Issued |
Array
(
[id] => 7152040
[patent_doc_number] => 20040171839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Polycyclic aryl and heteroaryl substituted 1, 4-quinones useful for selective inhibition of the coagulation cascade'
[patent_app_type] => new
[patent_app_number] => 10/753213
[patent_app_country] => US
[patent_app_date] => 2004-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64647
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20040171839.pdf
[firstpage_image] =>[orig_patent_app_number] => 10753213
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/753213 | Polycyclic aryl and heteroaryl substituted 1, 4-quinones useful for selective inhibition of the coagulation cascade | Jan 6, 2004 | Abandoned |
Array
(
[id] => 7297216
[patent_doc_number] => 20040214769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Estrogen receptors'
[patent_app_type] => new
[patent_app_number] => 10/752146
[patent_app_country] => US
[patent_app_date] => 2004-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7743
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214769.pdf
[firstpage_image] =>[orig_patent_app_number] => 10752146
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/752146 | Estrogen receptors | Jan 5, 2004 | Abandoned |
Array
(
[id] => 7151249
[patent_doc_number] => 20040171657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Microbicidal active substances'
[patent_app_type] => new
[patent_app_number] => 10/750810
[patent_app_country] => US
[patent_app_date] => 2003-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4582
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20040171657.pdf
[firstpage_image] =>[orig_patent_app_number] => 10750810
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/750810 | Microbicidal active substances | Dec 30, 2003 | Abandoned |
Array
(
[id] => 7326203
[patent_doc_number] => 20040138486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Process improvements in steroid chemistry'
[patent_app_type] => new
[patent_app_number] => 10/744857
[patent_app_country] => US
[patent_app_date] => 2003-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9272
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20040138486.pdf
[firstpage_image] =>[orig_patent_app_number] => 10744857
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/744857 | Process improvements in steroid chemistry | Dec 21, 2003 | Issued |
Array
(
[id] => 7378100
[patent_doc_number] => 20040220161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Pharmaceutical compositions and treatment methods-6'
[patent_app_type] => new
[patent_app_number] => 10/741929
[patent_app_country] => US
[patent_app_date] => 2003-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 111997
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20040220161.pdf
[firstpage_image] =>[orig_patent_app_number] => 10741929
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/741929 | Pharmaceutical compositions and treatment methods-6 | Dec 18, 2003 | Abandoned |
Array
(
[id] => 6972292
[patent_doc_number] => 20050038002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Substituted tetracycline compounds'
[patent_app_type] => utility
[patent_app_number] => 10/740961
[patent_app_country] => US
[patent_app_date] => 2003-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25414
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20050038002.pdf
[firstpage_image] =>[orig_patent_app_number] => 10740961
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/740961 | Substituted tetracycline compounds | Dec 17, 2003 | Issued |
Array
(
[id] => 5614431
[patent_doc_number] => 20060116359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => '17.Beta-(alpha-hydroxy)-esters of androstanes as intermediates for the preparation of 17.beta-fluorinated-androstane esters'
[patent_app_type] => utility
[patent_app_number] => 10/538083
[patent_app_country] => US
[patent_app_date] => 2003-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11878
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20060116359.pdf
[firstpage_image] =>[orig_patent_app_number] => 10538083
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/538083 | 17.Beta-(alpha-hydroxy)-esters of androstanes as intermediates for the preparation of 17.beta-fluorinated-androstane esters | Dec 17, 2003 | Abandoned |
Array
(
[id] => 7740619
[patent_doc_number] => 08106035
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-31
[patent_title] => '25-SO2-substituted analogs of 1μ,25-dihydroxyvitamin D3'
[patent_app_type] => utility
[patent_app_number] => 10/738248
[patent_app_country] => US
[patent_app_date] => 2003-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 12
[patent_no_of_words] => 42105
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/106/08106035.pdf
[firstpage_image] =>[orig_patent_app_number] => 10738248
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/738248 | 25-SO2-substituted analogs of 1μ,25-dihydroxyvitamin D3 | Dec 17, 2003 | Issued |
Array
(
[id] => 132865
[patent_doc_number] => 07696186
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-13
[patent_title] => '7,9-substituted tetracycline compounds'
[patent_app_type] => utility
[patent_app_number] => 10/738862
[patent_app_country] => US
[patent_app_date] => 2003-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10156
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/696/07696186.pdf
[firstpage_image] =>[orig_patent_app_number] => 10738862
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/738862 | 7,9-substituted tetracycline compounds | Dec 15, 2003 | Issued |
Array
(
[id] => 7310801
[patent_doc_number] => 20040142995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Thermally stable, anthraquinone colorants containing copolymerizable vinyl groups'
[patent_app_type] => new
[patent_app_number] => 10/734630
[patent_app_country] => US
[patent_app_date] => 2003-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10597
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20040142995.pdf
[firstpage_image] =>[orig_patent_app_number] => 10734630
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/734630 | Thermally stable, anthraquinone colorants containing copolymerizable vinyl groups | Dec 11, 2003 | Issued |
Array
(
[id] => 7672910
[patent_doc_number] => 20040180869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'New glucocorticoid receptor antagonists for prophylaxis and therapy of glucocorticoid-mediated hypogonadism, of sexual dysfunction and/or infertility'
[patent_app_type] => new
[patent_app_number] => 10/735487
[patent_app_country] => US
[patent_app_date] => 2003-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5250
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180869.pdf
[firstpage_image] =>[orig_patent_app_number] => 10735487
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/735487 | Glucocorticoid receptor antagonists for prophylaxis and therapy of glucocorticoid-mediated hypogonadism, of sexual dysfunction and/or infertility | Dec 11, 2003 | Issued |